Eli Lilly would further expand Indianapolis insulin manufacturing operations Eli Lilly announced that it is working closely with the city on a proposal to invest an additional $180M in the company's Indianapolis-based insulin manufacturing operations. The investment is in addition to the company's November 2012 announcement of a $140M expansion of the company's Indianapolis insulin manufacturing operations. Lilly also is proposing several other ancillary investment projects totaling about $80 million, including a $40 million product-inspection center.
Cowen to hold a conference 35th Annual Health Care Conference is being held in Boston on March 2-4 with webcasted company presentations to begin on March 3 at 8 am; not all company presentations may be webcasted. Webcast Link